These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32196727)

  • 21. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.
    Shapiro JA; Bobo JK; Church TR; Rex DK; Chovnick G; Thompson TD; Zauber AG; Lieberman D; Levin TR; Joseph DA; Nadel MR
    Am J Gastroenterol; 2017 Nov; 112(11):1728-1735. PubMed ID: 29016558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of two commercial test kits for detection of occult blood in feces of dogs.
    Gilson SD; Parker BB; Twedt DC
    Am J Vet Res; 1990 Sep; 51(9):1385-7. PubMed ID: 2396786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Colorectal Neoplasia in a Cohort Before and After the Change of Fecal Occult Blood Test in a French Colorectal Cancer Screening Program.
    Koïvogui A; Mab GL; Benamouzig R
    Am J Gastroenterol; 2018 Dec; 113(12):1891-1899. PubMed ID: 30337703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance of guaiac-based fecal occult blood test in routine screening: state-wide analysis from Bavaria, Germany.
    Brenner H; Hoffmeister M; Birkner B; Stock C
    Am J Gastroenterol; 2014 Mar; 109(3):427-35. PubMed ID: 24343548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of season and ambient temperature on outcome of guaiac-based faecal occult blood tests performed for colorectal cancer screening.
    Hunter JP; Saratzis A; Froggatt P; Harmston C
    Colorectal Dis; 2012 Sep; 14(9):1084-9. PubMed ID: 22122559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
    Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
    Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.
    Denis B; Ruetsch M; Strentz P; Vogel JY; Guth F; Boyaval JM; Pagnon X; Ebelin JF; Gendre I; Perrin P
    Gut; 2007 Nov; 56(11):1579-84. PubMed ID: 17616542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-invasive screening for colorectal cancer in Asia.
    Chiu HM; Chang LC; Hsu WF; Chou CK; Wu MS
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):953-65. PubMed ID: 26651256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: evidentiary base and recommendations.
    Rabeneck L; Zwaal C; Goodman JH; Mai V; Zamkanei M
    Clin Biochem; 2008 Nov; 41(16-17):1289-305. PubMed ID: 18796300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
    Hol L; van Leerdam ME; van Ballegooijen M; van Vuuren AJ; van Dekken H; Reijerink JC; van der Togt AC; Habbema JD; Kuipers EJ
    Gut; 2010 Jan; 59(1):62-8. PubMed ID: 19671542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Transitioning From Guaiac-Fecal Occult Blood Testing to Fecal Immunochemical Testing in a Canadian Colon Cancer Screening Program.
    Sultanian R; Du L; Moysey B; Morse A; Veldhuyzen van Zanten S; Montano-Loza AJ
    J Can Assoc Gastroenterol; 2020 Aug; 3(4):177-184. PubMed ID: 32671327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender-specific cut-offs in colorectal cancer screening with FIT: Increased compliance and equal positivity rate.
    Blom J; Löwbeer C; Elfström KM; Sventelius M; Öhman D; Saraste D; Törnberg S
    J Med Screen; 2019 Jun; 26(2):92-97. PubMed ID: 30336730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.
    Rozen P; Knaani J; Samuel Z
    Dig Dis Sci; 1997 Oct; 42(10):2064-71. PubMed ID: 9365136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
    Meklin J; SyrjÄnen K; Eskelinen M
    Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable.
    Sinatra MA; St John DJ; Young GP
    Clin Chem; 1999 Jan; 45(1):123-6. PubMed ID: 9895348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience with a two-tier reflex gFOBT/FIT strategy in a national bowel screening programme.
    Fraser CG; Digby J; McDonald PJ; Strachan JA; Carey FA; Steele RJ
    J Med Screen; 2012 Mar; 19(1):8-13. PubMed ID: 22156144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rectally obtained fecal samples can be used for fecal occult blood testing in dogs, and fecal immunochemical tests do not detect canine or feline blood.
    Chappell K; Van Vertloo L; Viall A; Scaccianoce J; LeVine DN
    Am J Vet Res; 2024 Jan; ():1-7. PubMed ID: 38262140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use.
    Santare D; Kojalo I; Huttunen T; Rikacovs S; Rucevskis P; Boka V; Leja M
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):536-43. PubMed ID: 25806603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cause of Death, Mortality and Occult Blood in Colorectal Cancer Screening.
    Kaalby L; Al-Najami I; Deding U; Berg-Beckhoff G; Steele RJC; Kobaek-Larsen M; Shaukat A; Rasmussen M; Baatrup G
    Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunochemical faecal occult blood tests have superior stability and analytical performance characteristics over guaiac-based tests in a controlled in vitro study.
    Lee CS; O'Gorman P; Walsh P; Qasim A; McNamara D; O'Morain CA; Boran GP
    J Clin Pathol; 2011 Jun; 64(6):524-8. PubMed ID: 21512110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.